To document a case of diffuse subretinal fibrosis and uveitis syndrome occurring alongside vitreoretinal traction syndrome in an older female patient, highlighting the 4-year gap between symptom onset in each eye.
Key Findings:
The patient exhibited a 4-year gap between the onset of symptoms in each eye.
Bilateral SFU syndrome was complicated by VRT syndrome and retinal neovascularization.
Anti-VEGF therapy provided a partial therapeutic response for macular edema, highlighting the need for tailored management.
Interpretation:
SFU syndrome is a rare inflammatory condition with a complex clinical presentation and challenging treatment options, emphasizing the need for careful diagnosis and individualized management strategies.
Limitations:
Limited clinical accounts and evidence-driven treatment strategies for SFU syndrome, highlighting the need for more comprehensive case reports.
Inconsistent clinical trajectories and absence of uniform management protocols, which complicate treatment outcomes.
Conclusion:
SFU syndrome is uncommon and can present with significant complications. Treatment may delay subretinal fibrosis progression, and anti-VEGF therapy can help manage associated macular edema, underscoring the importance of tailored approaches in future cases.
In the management of stage I testicular cancer, a persistent clinical dilemma is the identification of patients who truly need adjuvant treatment after orchiectomy rather than active surveillance alon...
Despite compelling prognostic associations across multiple retrospective data sets, no interventional trial has demonstrated that acting on circulating tumor DNA testing results in early breast cancer...
